Nicholas Maestas
Net worth: 903 $ as of 2026-05-30
Net worth: 903 $ as of 2026-05-30
Nicholas Maestas is currently Chief Financial & Accounting Officer at Rani Therapeutics Holdings, Inc. since 2026.
Formerly, Mr. Maestas was Chief Financial Officer, Secretary & Head-Strategy at Tempest Therapeutics, Inc. from 2025 to 2026, Head-Financial Planning & Analysis at Alector, Inc. from 2019 to 2021, and Senior Director-Corporate Development & Operations at Immune Design Corp.
in 2019.
Mr. Maestas completed undergraduate education at the University of California, Berkeley.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-30 | 590 ( 0% ) | 903 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| RANI THERAPEUTICS HOLDINGS, INC. | Director of Finance/CFO | 2026-06-28 |
| Companies | Position | End |
|---|---|---|
| TEMPEST THERAPEUTICS, INC. | Director of Finance/CFO | 2026-06-04 |
| ALECTOR, INC. | Corporate Officer/Principal | 2021-06-30 |
| IMMUNE DESIGN CORP | Corporate Officer/Principal | 2019-06-30 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immune Design Corp.
Immune Design Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and clinical-stage immunotherapy company | Health Technology |
Alector, Inc.
Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tempest Therapeutics, Inc.
Tempest Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology pharmaceuticals | Health Technology |
Rani Therapeutics Holdings, Inc.
Rani Therapeutics Holdings, Inc. BiotechnologyHealth Technology Engages in research and development of orally administered biological products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions